MAOB and Alzheimer disease: For example, ladostigil is a dual cholinesterase–monoamine oxidase-B (MAO-B) inhibitor currently being researched for the treatment of Alzheimer's disease and other neurodegenerative diseases (van der Schyf, 2011).